Parametric analyses in randomized clinical trials

Parametric Analyses In Randomized Clinical Trials

Blindness in Randomized Controlled Trials

In combination with randomization, blinding or masking is an important factor in randomized controlled trials (RCTs), particularly in trials that assess therapeutic effects. Here an attempt is made to explain blindness and why it is important. In clinical trials, blinding is defined as the condition imposed on a study in which study participants, health care providers and assessors collecting o...

Parametric Competing Risks Models in Clinical Trials

Some fully general parametric competing risks models, which allow the underlying (possibly dependent) lifetimes to be modeled as a function of an arbitrary number of covariables, are formulated, and their resulting likelihood function is derived. Under carefully stated regularity conditions, large sample tests of hypotheses concerning the model parameters are obtained for the single point trunc...

Randomized Clinical Trials in HFpEF

Heart Failure With Preserved Ejection Fraction Heart failure with preserved ejection fraction (HFpEF) or diastolic heart failure (HF) accounts for approximately half of HF cases in the community, and the portion of HF with preserved ejection fraction (EF) is increasing. Patients with HFpEF have limited functional capacity and poor prognosis. With ongoing shifts in the age distribution of the po...

Meta-analyses of randomized controlled trials.

A new type of research, termed meta-analysis, attempts to analyze and combine the results of previous reports. We found 86 meta-analyses of reports of randomized controlled trials in the English-language literature. We evaluated the quality of these meta-analyses, using a scoring method that considered 23 items in six major areas--study design, combinability, control of bias, statistical analys...